Gentex Corp
GNTX
ISIN null / Valor 933761
Gentex Corp
UMushroom community rating:
About company
Gentex Corporation, originally a custom helmet manufacturer, transitioned to designing and manufacturing aircrew respiratory products after being acquired by Protection, Inc. in 1969. The company's core competency expanded to include hearing protection and communication systems through acquisitions and organic investments, with a focus on providing solutions for defense, emergency response, and industrial safety customers. Gentex Corporation continues to lead globally in the design and manufacture of oxygen masks, chemical and biological respirators, as well as hearing protection and communication products. The company's commitment to R&D has led to the development of innovative passive and active noise reduction technologies, enhancing situational awareness and speech intelligibility for its customers.
Summarized from source with an LLMView SourceSector: Consumer CyclicalsLatest Results (17.11.2025):
Gentex Corp’s Q3 2025 report highlights a strong quarter with consolidated net sales of $655.2 million, representing an 8% increase compared to Q3 2024. The results emphasize both robust top‐line growth and solid margin improvements with enhanced gross margins and profitability. The company also reported successful capital returns through share repurchases, and guidance for the remainder of 2025 has been updated to reflect current market conditions and future objectives.
Sales Performance
Consolidated net sales reached $655.2 million, with core Gentex (excluding VOXX) net sales of $570.3 million. This marks an 8% increase over Q3 2024, underlining strong market demand and effective sales strategies.
Margin Improvements
Consolidated gross margin improved by 90 basis points to 34.4%, while the core Gentex gross margin increased to 34.9%—up from 33.5% in Q3 2024. These enhancements highlight improved operational efficiency and product mix optimization.
Profitability
The quarter delivered consolidated income from operations of $122.3 million and consolidated net income attributable to Gentex of $101.0 million. Earnings per diluted share amounted to $0.46, reflecting solid profitability during Q3 2025.
Share Repurchases
Gentex Corp repurchased 1.0 million shares during the quarter at a total cost of $28.3 million, emphasizing the company’s commitment to returning capital to shareholders.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
4909 M
Market cap (USD)
2,147,115
Daily traded volume (Shares)
28.92 / 28.57
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
